GL SOMATROPIN 100 IU (10 VIALS / 10 IU)
GL SOMATROPIN , Somatropin GL HGH 191 from a well-known company in the field of sports nutrition is really a new step in the development of sports pharmacology.
Genetic Labs’ growing husband is a new high-quality product that will soon occupy its niche in the lives of athletes around the world.
Today the drug can be purchased in Russia. To do this, simply place an order in the peptidrosta.ru store.
CHARACTERISTICS OF SOMATROPIN GL HGH 191
Genetic Labs has a long history of working in the field of sports pharmacology, and the company’s specialists know exactly what professional athletes need.
This is why the company has developed a new drug different from the rest of the peptides. The creative work has been going on for a long time.
The fact is that specialists have tried to develop a product formula of such high quality and unique that Somatropin HGH 191 has become a universal assistant for athletes of different levels.
Growth hormone deficiency in adults
At the start of treatment with somatropin, low initial doses of 0.15 – 0.3 mg are recommended as daily subcutaneous injections. The dose should be gradually adjusted and monitored by serum growth factor (IGF-I) levels. The final dose rarely exceeds 1.0 mg per day. As a general rule, the lowest effective dose should be administered. In elderly or overweight patients, lower doses may be necessary.
Women may require higher doses than men, with men showing increasing sensitivity to IGF-I over time. This means that there is a risk that women, especially those receiving oral estrogen therapy, are under-treated while men are over-treated.
Side effects :
Security profile summary:
Clinical trials have included approximately 530 patients treated with Somatropin Biopartners. The
side effects that occurred were rather transient in nature and their severity was
generally mild to moderate. The safety profile of Somatropin Biopartners is globally
identical to that, well known, of daily treatments with growth hormone. The effects
most commonly reported adverse reactions were injection site reactions,
peripheral edema, headache, myalgia, arthralgia, paraesthesia, hypothyroidism and
decrease in free thyroxine.
The following side effects have been seen during treatment with Somatropin Biopartners:
during a 6-month controlled clinical study including 151 adult patients with
GH appeared in adulthood or during childhood and in a 6-month extension study. The
other side effects from publications related to daily treatment with
growth hormone are indicated by an asterisk.
– Blood and lymphatic system disorders
Common: Decrease or increase in white blood cell count, increase in rate
glycosylated hemoglobin, decreased hemoglobin
– Infections and infestations
– Benign, malignant and unspecified tumors (including cysts and polyps)
Common: Tumor progression (1 case of tumor progression in a patient with a history
neurofibromatosis and radiotherapy), skin tag, craniopharyngioma
– Immune system disorders
Common: Production of antibodies to growth hormone
Common: Adrenal insufficiency, decreased free thyroxine, decreased triiodothyronine
free, increased blood TSH, hypothyroidism